Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cholangiocarcinoma
• Colorectal Cancer
• Gastric Cancer
• Melanoma
• Ovarian Cancer
• Peritoneal Cancer
• Renal Cell Carcinoma

Drugs mentioned

• TRK-950

Snippet

Sponsor: Toray Industries, Inc | Conditions: Solid Tumor, Colorectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING